TUBERCULOUS PLEURAL EFFUSION IN THE PREVIOUSLY HEALTHY MAN-CASE REPORT AND REVIEW OF THE LITERATURE
Introduction: Although pleural effusion is a common clinical manifestation, the differential diagnosis of the cause of the pleural effusion is often challenging, especially in the early differentiation of tuberculous pleurisy (TP) from other pleural effusion.
Case report: We present a previously healthy man who had no contagious or TB contact but developed massive tuberculous pleural effusion which eventually was unexpected tuberculous. He started with therapy per protocol and feeling well. The purpose of this case and review of literature was to remind the physicians that tuberculosis is not a sickening illness, but on the contrary, it is in the expansion.
Discussion: When a patient presents with new pleural effusion, the diagnosis of tuberculous pleuritis should be considered. The patient is at great risk for developing pulmonary or extra pulmonary TB if the diagnosis is not made properly. Between 3% and 25% of patients with TB will have TB pleuritic or more in immunocompromised patients.The treatment for TB pleuritis is the same as that for pulmonary TB.
Conclusion:The gold standard for the diagnosis of tuberculous pleural effusion remains the detection of Mycobacterium tuberculosis in pleural fluid, or pleural biopsy specimens, either by microscopy and/or culture, or the histological demonstration of caseating granulomas in the pleura along with acid fast bacilli.
Global tuberculosis report 2015. Geneva: World Health Organization, 2015.
Baumann MH, Nolan R, Petrini M, Lee YC, Light RW, Schneider E. Pleural tuberculosis in the United States: incidence and drug resistance. Chest 2007; 131(4):1125-32.
Light RW. Update on tuberculous pleural effusion. Respirology. 2010; 15(3):451-8.
Light RW. Pleural diseases. 6th edition. Philadelphia: Lippincott Williams & Wilkins; 2013.
Chadha SL, Bhagi RP. Treatment outcome in tuberculosis patients placed under directly observed treatment short course (dots) -a cohort study. Ind J Tub. 2000; 47(3):155-8.
Udwadia ZF, Sen T. Pleural tuberculosis: An update. Curr Opin Pulm Med. 2010; 16(4):399-406.
Dutt AK, Moers D, Stead WW. Tuberculous pleural effusion: 6-month therapy with isoniazid and rifampin. Am Rev Respir Dis. 1992; 145(6):1429–32.
Valdes L, Alvarez D, San Jose E, Penela P, Valle JM, García-Pazos JM et al. Tuberculous pleurisy: a study of 254 patients. Arch Intern Med. 1998; 158(18):2017–21.
Seiscento M, Vargas FS, Bombarda S, Sales RK, Terra RM, Uezumi K et al. Pulmonary involvement in pleural tuberculosis: How often does it mean disease activity? Respir Med. 2011;105(7): 1079–83.
Porcel JM, Vives M. Etiology and pleural fluid characteristics of large and massive pleural effusions. Chest. 2003; 124(3):978–83.
Qiu L, Teeter LD, Liu Z, Ma X, Musser JM, Graviss EA.. Diagnostic associations between pleural and pulmonary tuberculosis. J Infect. 2006; 53(6):377–86.
Ong A, Creasman J, Hopewell PC, Gonzalez LC, Wong M, Jasmer RM et al. A molecular epidemiological assessment of extrapulmonary tuberculosis in San Francisco. Clin Infect Dis. 2004; 38(1):25–31.
Torgersen J, Dorman SE, Baruch N, Hooper N, Cronin W.. Molecular epidemiology of pleural and other extrapulmonary tuberculosis: a Maryland state review. Clin Infect Dis. 2006; 42(10):1375–82.
Aljohaney A, Amjadi K, Alvarez GG. A systematic review of the epidemiology, immunopathogenesis, diagnosis, and treatment of Pleural TB in HIV infected patients. Clin Dev Immunol. 2012:842045.
Saks AM, Posner R. Tuberculosis in HIV positive patients in South Africa: a comparative radiological stud with HIV negative patients. ClinRadiol. 1992; 46(6):387–90.
Institut za javno zdravlje, BATUT. Izveštaj o zaraznim bolestima u Republici Srbiji, 2018.god.Available on: www. batut.org.rs/ download /izvestaji/ Godisnji%20 izvestaj%20 zarazne%20bolesti%202017.pdf
Porcel JM. Tuberculous pleural effusion. Lung. 2009;187(5):263–70.
Payam N, Dorman SE, Alipanah N, Barry PM, Brozek JL, Cattamanchi A, et al. Official American Thoracic Society/ Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis. 2016; 63: 853-67.
Schunemann HJ, Jaeschke R, Cook DJ, Bria WF, El-Solh AA, Ernst A et al. An official ATS statement: grading the quality of evidence and strength of recommendations in ATS guidelines and recommendations. Am J RespirCrit Care Med. 2006; 174(5):605–14.
Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-Coello P et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2008; 336(7650):924–6.
- There are currently no refbacks.
Copyright (c) 2019 Biljana Lazovic, Ivana Blazic, Dzemail Detanac, Rade Milic, Sanja Sarac, Dzenana Detanac, Miodrag Vukcevic, Vladimir Zugic
This work is licensed under a Creative Commons Attribution 4.0 International License.